CPB handles tobacco-related litigation in both affirmative and defensive contexts. Typically, defensive cases challenge rulemakings or guidance issued by FDA’s Center for Tobacco Products, as well as product-specific determinations relating to the marketing of new tobacco products.

[updated April 2018]